Welcome to our dedicated page for Omega Healthcare SEC filings (Ticker: OHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Omega Healthcare Investors, Inc. (NYSE: OHI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Omega is a real estate investment trust focused on long-term healthcare real estate, and its filings offer detailed insight into how it finances and manages skilled nursing, assisted living and other healthcare-related properties in the United States and the United Kingdom.
Investors can review current reports on Form 8-K, where Omega reports material events such as new senior unsecured credit facilities, amendments to term loans, public offerings and redemptions of senior notes, and the establishment of at-the-market equity offering programs. These filings also describe key terms of debt instruments, including interest rates, maturities, covenants and guarantees, as well as amendments to executive employment agreements and other corporate actions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when available, provide broader context on Omega’s portfolio of long-term healthcare facilities, its use of triple-net leases, exposure to U.S. and U.K. markets and risk factors related to operator performance, reimbursement, regulation and capital markets. Proxy materials and other filings can include information on governance and executive compensation.
On Stock Titan, these documents are complemented by AI-powered summaries that highlight the main points from lengthy filings, helping users quickly understand changes in Omega’s capital structure, borrowing arrangements, equity issuance plans and relationships with healthcare operators. The filings page also surfaces insider-related disclosures, where applicable, so users can track material updates in one place while retaining the ability to read the full SEC documents for complete detail.
Omega Healthcare Investors reported an insider equity award for its President, Matthew Paul Gourmand. On January 8, 2026, he was granted 59,449 Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership at a price of $0 per unit, increasing his beneficial holdings in this derivative security to 95,482 PIUs. On the same date, he was also granted an additional 22,480 PIUs at $0, bringing his total beneficial ownership to 117,962 PIUs.
The PIUs relate to OP Units in the operating partnership and represent a contingent right to receive one OP Unit per PIU upon vesting and satisfaction of specified tax-related conditions. The awards were earned, but not yet vested, based on the company’s Absolute Total Shareholder Return for 2023–2025 and Relative Total Shareholder Return for 2022–2024, with vesting scheduled quarterly during 2026, subject to continued employment and certain acceleration events.
Omega Healthcare Investors reported an equity compensation grant to its Chief Accounting Officer, Neal Ballew. On January 8, 2026, Ballew was awarded 59,449 Profits Interest Units (PIUs) and a separate grant of 22,480 PIUs in OHI Healthcare Properties Limited Partnership, the operating partnership for the company. Each PIU represents a contingent right to receive one OP Unit, which is a limited partnership interest, once vesting and certain tax-related conditions are met.
The PIUs were earned, but not yet vested, based on Absolute and Relative Total Shareholder Return over the 2023–2025 performance period, as certified by the compensation committee. According to the award terms, 25% of the PIUs earned for this period will vest at the end of each quarter of 2026, subject to continued employment and possible accelerated vesting upon certain events.
Omega Healthcare Investors filed an amended insider trading report for its Chief Executive Officer and director. The filing restates details of a prior transaction in which the executive redeemed 200,000 OP Units in OHI Healthcare Properties Limited Partnership, each tied economically to one share of Omega Healthcare common stock. Each OP Unit was redeemed for cash based on the average closing price over ten trading days, confirmed here as $44.25 per share.
The amendment also notes that 20,000 underlying shares from this redemption were matchable with a purchase of 20,000 Omega Healthcare shares on November 5, 2025 under Section 16(b), and the executive has paid $22,144 to the company as short-swing profit. The company explains this amendment corrects a typographical error in the previously reported average price, while the actual redemption price and profit repayment figures remain the same.
Cohen & Steers and its affiliates report a 4.64% passive stake in Omega Healthcare Investors, Inc. They disclose beneficial ownership of 13,709,195 shares of Omega Healthcare common stock as of 12/31/2025, with sole voting power over 10,584,543 shares and sole dispositive power over the full 13,709,195 shares. The shares are held by Cohen & Steers Capital Management, Cohen & Steers UK, Cohen & Steers Asia, and Cohen & Steers Ireland for the benefit of their account holders, who are entitled to dividends and sale proceeds. Cohen & Steers, Inc. owns 100% of these subsidiaries and certifies that the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Omega Healthcare.
Omega Healthcare Investors, Inc. has amended the employment agreements of its named executive officers, extending their terms by one year to December 31, 2028 and updating annual salaries after a Compensation Committee review. The changes are most significant for President Matthew Gourmand and Chief Legal Officer and General Counsel Gail Makode.
Mr. Gourmand’s annual bonus opportunity was increased at all performance levels, with the high level rising to 200% of annual base salary, target to 125% and threshold to 75%. His severance in a termination without cause or with good reason was raised from two times to three times the sum of annual base salary and three-year average annual bonus, payable over three years, and his post-employment non-compete and non-solicit covenants were extended from two years to three years.
For Ms. Makode, severance in a termination without cause or with good reason was increased from one and a half times to two times the sum of annual base salary and three-year average annual bonus, payable over two years, and her post-employment non-compete and non-solicit covenants were lengthened from 18 months to two years.
Omega Healthcare Investors' chief financial officer reported an insider share transfer involving common stock of the company. On 12/31/2025, the officer made a gifted transfer of 31,426 shares of common stock at a stated price of $0, reflecting an estate planning move.
According to the filing, the transaction was a gift of shares to a revocable trust established for the benefit of the officer's spouse. Following this transaction, the officer beneficially owned 147,000 shares directly and 31,426 shares indirectly through the trust.
Omega Healthcare Investors chief accounting officer reported routine share activity involving company stock. On 01/01/2026, the officer acquired 173 shares of common stock at $35.89 through the company’s Employee Stock Purchase Plan, then disposed of 12 shares at $44.34 to cover tax withholding tied to that ESPP purchase. After these transactions, the officer directly beneficially owned 4,348 shares of common stock.
The filing also details vesting activity in performance-based and time-based Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership that convert into OP Units, and related redemptions of OP Units into common stock. On 12/31/2025, multiple tranches of PIUs vested into OP Units and OP Units were redeemed for an aggregate of 34,235 shares of common stock at a stated exercise price of $0, resulting in beneficial ownership of 127,839 shares of common stock after the reported derivative transactions.
Omega Healthcare Investors reported insider equity award activity for its President on a Form 4. On 12/31/2025, several tranches of Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership vested into OP Units, and OP Units were converted into common stock at an exercise price of $0 per unit. The derivative table shows vesting and conversions involving 11,627, 12,042 and 15,408 units or shares in multiple entries. The PIUs are performance- and time-based awards tied to Absolute and Relative Total Shareholder Return for the 2022–2024 period and a three-year time-based schedule, all subject to continued employment and potential accelerated vesting under certain circumstances.
Omega Healthcare Investors’ Chief Investment Officer reported several equity award transactions dated 12/31/2025. These involved Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership converting into OP Units, and OP Units converting into common stock at an exercise price of $0.
The filing shows 11,627, 12,042 and 15,408 PIUs vesting into OP Units based on performance and time-based criteria, and corresponding OP Units converting into the same numbers of shares of common stock. The PIUs and OP Units are subject to continued employment and, in some cases, performance based on absolute and relative total shareholder return for the 2022–2024 period, with potential accelerated vesting under certain circumstances.
Omega Healthcare Investors Inc. reported equity award activity for its Chief Legal Officer. On 12/31/2025, various Profits Interest Units (PIUs) in OHI Healthcare Properties Limited Partnership vested and converted into limited partnership units (OP Units), and certain OP Units were exchanged into common stock equivalents, all at a stated price of $0 per unit.
One transaction shows 11,627 PIUs converting into OP Units with 55,798 derivative securities then beneficially owned, with similar activity for blocks of 12,042 and 15,408 PIUs. OP Units can be redeemed for cash equal to the fair market value of one share of Omega Healthcare common stock, or, at the issuer’s election, one share of common stock. The PIUs are tied to performance over the 2022–2024 period and three-year time-based vesting, subject to continued employment and potential accelerated vesting in certain situations.